Medication info
Apomin Tablets (Metformin Hydrochloride)

Apomin Tablets (Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Pharmaking Co., Ltd.
Appearance
White round film-coated tablets
Packaging
100 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 201211104 · Approved 2012.12.31 · Insurance code 652301110

Summary

Main use
Treatment of type 2 diabetes mellitus inadequately controlled by diet and exercise
Who takes it
Adults · Children
Adult dose
The dose should be determined individually based on therapeutic response and tolerability, and should not exceed the recommended maximum daily dose. Start at a low dose and take 500mg per dose 2~3 times daily with meals. Increase the dose gradually by 500mg each week; when taking up to 2000mg, the dose is usually divided into two doses daily, in the morning and evening. For doses exceeding 2000mg, divide into three doses daily and take with meals; the maximum daily dose is 2550mg. Measure fasting blood glucose when initiating treatment and adjusting the dose, and measure glycated hemoglobin levels approximately every 3 months. The treatment goal is to reduce fasting blood glucose and blood glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose, either as monotherapy or in combination.
Child dose
Children 10 years of age and older or adolescents who are still growing: Administer 500mg once daily during or after a meal. Measure blood glucose levels after one week and adjust the dose; gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg, divided into 2~3 doses.

Ingredients

Manufacturer
Pharmaking Co., Ltd.

Efficacy & effects

Treatment of type 2 diabetes mellitus inadequately controlled by diet and exercise

  • Type 2 diabetes with insufficient blood sugar control
View approved original text

This medication is used for patients with type 2 diabetes who struggle to control blood sugar levels with diet and exercise alone, particularly overweight adult patients. Additionally, this medication can be used as monotherapy and, if necessary, can be combined with other oral hypoglycemic agents or insulin. It can also be used in children over 10 years and adolescents in growth as either monotherapy or in combination with insulin. This medication helps effectively control blood sugar to assist in diabetes management.

How to take

Adult dose

The dose should be determined individually based on therapeutic response and tolerability, and should not exceed the recommended maximum daily dose. Start at a low dose and take 500mg per dose 2~3 times daily with meals. Increase the dose gradually by 500mg each week; when taking up to 2000mg, the dose is usually divided into two doses daily, in the morning and evening. For doses exceeding 2000mg, divide into three doses daily and take with meals; the maximum daily dose is 2550mg. Measure fasting blood glucose when initiating treatment and adjusting the dose, and measure glycated hemoglobin levels approximately every 3 months. The treatment goal is to reduce fasting blood glucose and blood glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose, either as monotherapy or in combination.

Child dose

Children 10 years of age and older or adolescents who are still growing: Administer 500mg once daily during or after a meal. Measure blood glucose levels after one week and adjust the dose; gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg, divided into 2~3 doses.

Precautions

This medication should not be administered to patients with impaired kidney function. Serious side effects like lactic acidosis may occur if kidney function is moderately or severely impaired. This medication should not be used in patients with acute conditions such as acute infections, heart failure, or myocardial infarction. In such states, the risk may increase due to worsened kidney function. Patients who are scheduled to undergo examinations using iodine-based contrast agents should temporarily discontinue this medication for a certain period before and after the exam, and resume it only after confirming normal kidney function. This medication is not administered to patients who have had allergic reactions to it, patients with type 1 diabetes, or those with diabetic ketoacidosis. Patients with severe infections, significant trauma, or those undergoing surgery should temporarily stop taking this medication, and can resume it only after their condition has stabilized and kidney function is confirmed to be normal. Patients with poor nutritional status or those with decreased liver function, and patients who consume excessive alcohol should use this medication cautiously. Liver impairment may increase the risk of lactic acidosis. This medication can lead to a rare but life-threatening side effect called lactic acidosis, so patients and caregivers should immediately inform their doctor if symptoms of lactic acidosis such as muscle pain, difficulty breathing, fatigue, or abdominal pain occur. Gastrointestinal symptoms (diarrhea, nausea, vomiting, etc.) may occur initially, but they are usually temporary and improve over time. Taking the medication slowly and with meals can reduce symptoms. While this medication lowers blood sugar, it rarely causes hypoglycemia on its own. However, caution is needed as hypoglycemia may occur when taken with other hypoglycemic agents, when meals are skipped, or during intense exercise. Regular monitoring of kidney function, blood sugar, and vitamin B12 levels is recommended to ensure there are no issues. Particularly, elderly patients and those with decreased kidney function require more frequent monitoring. This medication may be used during pregnancy only under special circumstances and with a physician's judgment, but should not be used in pregnant women at risk of placental insufficiency or preeclampsia. If breastfeeding, a discussion with a doctor is necessary regarding whether to continue breastfeeding or to discontinue medication, as this medication can pass into breast milk. This medication may interact with other drugs, so it is essential to inform the doctor or pharmacist of any other medications being taken, and to closely monitor blood sugar and the patient’s condition. In case of overdose, the medication can be removed via hemodialysis, so if overdose is suspected, immediate medical attention is necessary. This medication should be stored out of reach of children, and it is advised to avoid transferring it to another container, as it can negatively affect the quality.

Side effects

  • Lactic acidosis
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • indigestion
  • constipation
  • abdominal pain
  • metallic taste
Show 7 more
  • rash
  • anemia
  • leukopenia
  • thrombocytopenia
  • vitamin B12 deficiency
  • liver function abnormalities
  • severe delayed hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air and moisture. It is recommended to store it at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

100 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.